Understanding Responses to Contradictory Information About Products

References

• Ahluwalia R. How prevalent is the negativity effect in consumer environments? J. Consumer Res. (2002) 29(2):270–279Crossref, Google Scholar
• Ahluwalia R., Burnkrant R. E., Unnava H. R. Consumer response to negative publicity: The moderating role of commitment. J. Marketing Res. (2000) 37(2):203–214Crossref, Google Scholar
• American Diabetes Association Statement from the American College of Cardiology, American Diabetes Association and American Heart Association related to NEJM article, “Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes”. (2007) . Press release (May 21), http://www.diabetes.org/for-media/2007/statement-from-the-aha-acc-ada-nejm-article-2007.htmlGoogle Scholar
• Bandura A. Self-efficacy mechanism in human agency. Amer. Psych. (1982) 37(2):122–147Crossref, Google Scholar
• Chan T., Narasimhan C., Xie Y. An empirical model of physician learning on treatment effectiveness and side-effects. (2010) . Working paper, Washington University in St. Louis, St. LouisGoogle Scholar
• Chib S., Greenberg E. Understanding the Metropolis-Hastings algorithm. Amer. Statistician (1995) 49(4):327–335Google Scholar
• Ching A. T. Consumer learning and heterogeneity: Dynamics of demand for prescription drugs after patent expiration. Internat. J. Indust. Organ. (2010) 28(6):619–638Crossref, Google Scholar
• Chintagunta P. K., Jiang R., Jin G. Z. Information, learning and drug diffusion: The case of Cox-2 inhibitors. Quant. Marketing Econom. (2009) 7(4):399–433Crossref, Google Scholar
• Cleeren K., Dekimpe M. G., Helsen K. Weathering product-harm crises. J. Acad. Marketing Sci. (2008) 36(2):262–270Crossref, Google Scholar
• CTC Helmets. . Accessed February 2009, http://www.ctc.org.uk/resources/Campaigns/Helmets.pdfGoogle Scholar
• Dawar N., Pillutla M. M. Impact of product-harm crises on brand equity: The moderating role of consumer expectations. J. Marketing Res. (2000) 37(2):215–226Crossref, Google Scholar
• Dong X., Manchanda P., Chintagunta P. K. Quantifying the benefits of individual-level targeting in the presence of firm strategic behavior. J. Marketing Res. (2009) 46(2):207–221Crossref, Google Scholar
• Erdem T., Keane M. P. Decision-making under uncertainty: Capturing dynamic brand choice process in turbulent consumer goods markets. Marketing Sci. (1996) 15(1):1–20Link, Google Scholar
• European Medicines Agency European Medicines Agency confirms positive benefit-risk balance for rosiglitazone and pioglitazone. (2007) . Press release (October 18), http://www.emea.europa.eu/docs/en_GB/document_library/Press_release/2009/11/WC5000011009.pdfGoogle Scholar
• Gelfand A. E., Smith A. F. M. Sampling-based approaches to calculating marginal densities. J. Amer. Statist. Assoc. (1990) 85(410):398–409Crossref, Google Scholar
• Gist M. E., Mitchell T. R. Self-efficacy: A theoretical analysis of its determinants and malleability. Acad. Management Rev. (1992) 17(2):183–211Crossref, Google Scholar
• Hoff T. H., Whitcomb W. F., Williams K., Nelson J. R., Cheesman R. A. Characteristics and work experiences of hospitalists in the United States. Arch. Internal Medicine (2001) 161(6):851–858Crossref, Google Scholar
• Manchanda P., Ansari A., Gupta S. The “shopping basket”: A model for multi-category purchase incidence decisions. Marketing Sci. (1999) 18(2):95–114Link, Google Scholar
• Manchanda P., Rossi P., Chintagunta P. Response modeling with nonrandom marketing-mix variables. J. Marketing Res. (2004) 41(4):467–478Crossref, Google Scholar
• McGuire S. FDA toughens Avandia warnings. (2007) . Medical Marketing & Media (November 14) http://www.mmm-online.com/fda-toughens-avandia-warnings/article/96354Google Scholar
• Mehta N., Chen X., Narasimhan O. Informing, transforming, and persuading: Disentangling the multiple effects of advertising on brand choice decisions. Marketing Sci. (2008) 27(3):334–355Link, Google Scholar
• Narayanan S., Manchanda P. Heterogeneous learning and the targeting of marketing communication for new products. Marketing Sci. (2009) 28(3):424–441Link, Google Scholar
• Narayanan S., Manchanda P., Chintagunta P. K. Temporal differences in the role of marketing communication in new product categories. J. Marketing Res. (2005) 42(3):278–290Crossref, Google Scholar
• Nissen S., Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. New Engl. J. Medicine (2007) 356(24):2457–2471Crossref, Google Scholar
• Psaty B. M., Furberg C. D. Editorials: Rosiglitazone and cardiovascular risk. New Engl. J. Medicine (2007) 356(24):2522–2524Crossref, Google Scholar
• Rodgers G. B. Reducing bicycle accidents: A re-evaluation of the impacts of the CPSC bicycle standard and helmet use. J. Products Liability (1988) 11(11):307–317Google Scholar
• Rossi P. E., McCulloch R. E., Allenby G. M. The value of purchase history data in target marketing. Marketing Sci. (1996) 15(4):321–340Link, Google Scholar
• Sun B., Li S. Learning and acting on customer information: A simulation-based demonstration on service allocations with offshore centers. J. Marketing Res. (2011) 48(1):72–86Crossref, Google Scholar
• Tanner M. A., Wong W. H. The calculation of posterior distributions by data augmentation. J. Amer. Statist. Assoc. (1987) 82(398):528–540Crossref, Google Scholar
• Thompson R. S., Rivara F. P., Thompson D. C. A case control study of the effectiveness of bicycle safety helmets. New Engl. J. Medicine (1989) 320(21):1361–1367Crossref, Google Scholar
• U.S. House of Representatives FDA's role in the evaluation of Avandia's safety. (2007) . Prepared statement of Brian L. Storm. Hearing, Committee on Oversight and Government Reform, 110th Cong., 1st sess., June 7Google Scholar
• Van Heerde H., Helsen K., Dekimpe M. G. The impact of a product-harm crisis on marketing. Marketing Sci. (2007) 26(2):230–245Link, Google Scholar